Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Invatec

1996 FOUNDED
M&A STATUS
801-900 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Provider of vascular interventional products for the treatment of cardiovascular disease. The company offers endovascular treatment of critical limb ischemia, carotid artery stenting and provides drug eluting balloon, treating arteries in the coronary and the upper/lower leg for the purpose of maximizing the long term patency of diseased vessels.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Surgical Devices
Acquirer
Golden Max
Primary Office
  • Via Martiri della Libertà 7
  • 25030 Roncadelle
  • Italy

Invatec Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Invatec‘s full profile, request access.

Request full access to PitchBook

Invatec Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Invatec‘s full profile, request access.

Request full access to PitchBook